NCT01595269
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Calgary Health Region's offices across southwestern Alberta Lethbridge, Alberta, Canada
Clinical trial condition
Diabetes Mellitus, Type 2
Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.
7,974 public trials
716 recruiting studies
Diabetes Mellitus, Type 2 trial results
NCT01572402
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +5 more
- Locations
-
- Hana Kahleova Prague, Czechia
NCT01593371
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
- Locations
-
- Tehran University of Medical Sciences Tehran, Tehran Province, Iran
NCT00971516
- Conditions
- Dental Implants, Diabetes Mellitus, Diabetes Mellitus, Type 2, +5 more
- Locations
-
Not specified
Completed
A Study to Assess the Effects of Vildagliptin on Gastric Emptying in Patients With Type 2 Diabetes
NCT00351507
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Mayo Clinic Rochester, Minnesota, United States
NCT00099866
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Novartis investigative Site Investigative Sites, Germany
NCT00101712
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Novartis Investigative Site Investigative Site, Germany
- Novartis Investigative Site Basel, Switzerland
NCT00351585
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
Not specified
NCT01386541
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
- Locations
-
- Nycomed Investigational site Mannheim, Germany
Completed
Efficacy and Safety of Vildagliptin Compared to Acarbose in Drug Naive Patients With Type 2 Diabetes
NCT00110240
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Novartis Pharmaceuticals Basel, Switzerland